4.49 USD
↗ 0.02 (0.45%)AT CLOSE (11:59 AM EDT)
CAMP4 Therapeutics Corporation Common Stock
CAMPNASDAQ • USD
4.49
↘ 0.00 (0.09%)
POST MARKET (AS OF 06:29 PM EDT)
Post Market
AS OF 06:29 PM EDT
4.49
↘ 0.00 (0.09%)
Market: OPEN
Open?$4.51
High?$4.72
Low?$4.43
Prev. Close?$4.47
Volume?69.1K
Avg. Volume?307.3K
VWAP?$4.48
Rel. Volume?0.22x
Bid / Ask
Bid?$4.47 × 100
Ask?$4.50 × 100
Spread?$0.03
Midpoint?$4.48
Valuation & Ratios
Market Cap?232.1M
Shares Out?51.9M
Float?24.9M
Float %?53.1%
P/E Ratio?N/A
P/B Ratio?4.86
EPS?-$1.55
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.27Strong
Quick Ratio?7.27Strong
Cash Ratio?7.06Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score58/100
P/E?N/A▾
P/B?4.86FAIR▾
P/S?66.35HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.4CHEAP▾
EV/Sales?35.04HIGH▾
Returns & Efficiency
ROE?-168.6%WEAK▾
ROA?-68.3%WEAK▾
Cash Flow & Enterprise
FCF?$-29832000
Enterprise Value?$122.6M
Related Companies
Loading...
News
Profile
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
Employees
48
Market Cap
232.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-11
Address
ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
Phone: 617-651-8867
CAMBRIDGE, MA 02139
Phone: 617-651-8867